other_material
confidence high
sentiment negative
materiality 0.65
KALA BIO CEO Lazar sells Series AAA preferred rights; consultant hired for strategic alternatives
KALA BIO, Inc.
- Annual meeting set for Jan 30, 2026; stockholder proposals and director nominations due Dec 27, 2025.
- David Lazar sold his rights to purchase Series AAA Preferred Shares (up to $4.2M) to unaffiliated AK Holdings Group Inc.
- Company retains consultant, a principal of AK Holdings, to advise on identifying and consummating a strategic alternative transaction.